Cryopraxis
Cell Biology · Cryopreservation
Issue No. 12 · Review Commentary

Adipose tissue and alopecia: mechanisms and clinical progress of fat-derived cells in hair loss

Commentary on the open-access review by Zhang et al., Stem Cell Research & Therapy (2025)
Issue · No. 12
Audience · Physicians
DOI · 10.1186/s13287-025-04560-7

Quick answer: adipose tissue derivatives — adipose-derived mesenchymal stem cells (ADSCs), stromal vascular fraction (SVF), conditioned medium (ADSC-CM) and exosomes (ADSC-Exos) — increased hair density and thickness in preclinical and early clinical studies of androgenetic alopecia and alopecia areata. The review concludes that the approach is promising but still requires large clinical trials, standardization and long-term safety data.

Context

Why hair loss is a clinical challenge

More than 50% of the population is expected to experience some degree of hair loss during their lifetime. Androgenetic alopecia (AGA) accounts for approximately 90% of cases: follicles sensitive to dihydrotestosterone (DHT) progressively shrink, and the growth phase (anagen) becomes shorter. Alopecia areata (AA) has an autoimmune origin.

According to the authors, only two medications have FDA approval for AGA — finasteride and minoxidil — both with potential adverse effects and a need for ongoing use. This explains the interest in strategies that act on the follicular microenvironment.

Mechanisms

How adipose tissue derivatives act on the hair follicle

1

Paracrine signaling

Factors such as VEGF, HGF, IGF-1, bFGF and PDGF stimulate dermal papilla cells and prolong the anagen phase.

2

Wnt/β-catenin pathway

Exosomes rich in Wnt proteins activate the central pathway for follicle formation and regeneration.

3

Angiogenesis

Greater blood vessel density around the follicle improves nutrient supply.

4

Immune modulation

A reduction in the inflammatory response, particularly relevant in alopecia areata.

Clinical evidence

What patient studies show

DerivativeFindings reported in the review
Conditioned medium (ADSC-CM)Increased hair density and count in AGA and female pattern hair loss, alone or combined with non-ablative fractional laser or minoxidil; no significant adverse events in the cited studies.
Stromal vascular fraction (SVF)Gains in density and diameter in AA within 3–6 months; SVF-enriched fat grafting outperformed fat grafting alone; combination with PRP increased hair density and count.
Exosomes (ADSC-Exos)In 39 patients, application with microneedling over 12 weeks increased hair density and thickness.
PreconditioningHypoxia and pharmacological stimuli (such as minoxidil) increased the secretion of pro-regenerative factors in the laboratory.
90%
of hair loss cases are androgenetic alopecia
48%
improvement in density in retrospective SVF analyses
Limitations

What is still needed

The authors highlight small, heterogeneous studies, a lack of standardized production and dosing protocols, the high cost of SVF isolation, and limited data on long-term safety and durability. Randomized controlled clinical trials are still needed.

Cryopraxis perspective: the review reinforces adipose tissue's position as one of the most studied biological sources in regenerative medicine — and shows that hair regeneration using its derivatives remains at the clinical research stage.

Relevance to LipAge

Preserving tissue collected during liposuction today

LipAge cryopreserves a portion of the adipose tissue from an already planned liposuction procedure at a Cell Technology Center licensed by ANVISA (Brazil's health regulatory agency). This is autologous material, stored for future use upon medical indication, in accordance with regulated and available applications.

Regulatory note

LipAge does not offer procedures for alopecia. This content summarizes a third-party scientific publication for educational purposes and does not constitute a promise of results.

Frequently asked questions

Common questions

Can adipose tissue help with hair loss?
Early studies indicate increased hair density and thickness, but large trials and standardization are still lacking.

What is SVF?
A mixture of cells from adipose tissue (mesenchymal, endothelial and immune cells) that can be isolated during the same liposuction procedure.

Does LipAge offer anything for alopecia?
No. LipAge preserves autologous material for future use upon medical indication.

References

1. Zhang J, Chen F, Hu Y, Cong X. Mechanisms and clinical progress of adipose-derived stem cells and their derivatives in the treatment of hair loss. Stem Cell Research & Therapy. 2025;16:439. DOI: 10.1186/s13287-025-04560-7. CC BY 4.0 License.

2. Widowati W et al. Hair regeneration in alopecia using adipose-derived mesenchymal stem cells secretome: a systematic review. Tissue and Cell. 2027;104:103872. DOI: 10.1016/j.tice.2026.103872 (LipAge Newsletter No. 11).

The primary clinical studies mentioned are listed in the references of article 1.

Would you like to discuss LipAge?

Contact the Cryopraxis team about adipose tissue collection and cryopreservation.

WhatsApp Read the article